Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 1, keine Gesamtzahl für „investigated“
Suchtreffer
Begriffe & Kennungen
Accofil · 4.5 · Possible interactions with other haematopoietic growth factors and cytokines have not yet been investigated in
Eintrag öffnenAccofil · 4.5 · Possible interactions with other haematopoietic growth factors and cytokines have not yet been investigated in
Eintrag öffnenAccofil · 4.5 · Possible interactions with other haematopoietic growth factors and cytokines have not yet been investigated in
Eintrag öffnenAccofil · 4.5 · Possible interactions with other haematopoietic growth factors and cytokines have not yet been investigated in
Eintrag öffnenAdempas · 4.5 · Concomitant use with CYP1A1, UGT1A1 and UGT1A9 inhibitors From the recombinant CYP isoforms investigated in vi
Eintrag öffnenAdempas · 4.5 · Concomitant use with CYP1A1, UGT1A1 and UGT1A9 inhibitors From the recombinant CYP isoforms investigated in vi
Eintrag öffnenAdempas · 4.8 · The safety of riociguat has been investigated in 24 paediatric patients aged 6 to less than 18 years over 24 w
Eintrag öffnenAdempas · 4.8 · The safety of riociguat has been investigated in 24 paediatric patients aged 6 to less than 18 years over 24 w
Eintrag öffnenAldara · 4.8 · Imiquimod was investigated in controlled clinical studies with paediatric patients (see sections 4.2 and 5.1).
Eintrag öffnenApixaban Accord · 4.8 · Summary of the safety profile In adults, the safety of apixaban has been investigated in 7 Phase III clinical
Eintrag öffnenApixaban Accord · 4.8 · Summary of the safety profile In adults, the safety of apixaban has been investigated in 7 Phase III clinical
Eintrag öffnenApixaban Accord · 4.8 · The safety of apixaban has been investigated in 1 Phase I and 3 Phase II/III clinical studies including 970 pa
Eintrag öffnenApixaban Accord · 4.8 · The safety of apixaban has been investigated in 1 Phase I and 3 Phase II/III clinical studies including 970 pa
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.5 · Potential interactions between brivaracetam (50 mg/day to 200 mg/day) and other AEDs were investigated in a po
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.5 · Potential interactions between brivaracetam (50 mg/day to 200 mg/day) and other AEDs were investigated in a po
Eintrag öffnenBriviact (in Italy: Nubriveo) · 4.5 · Potential interactions between brivaracetam (50 mg/day to 200 mg/day) and other AEDs were investigated in a po
Eintrag öffnenCamzyos · 4.5 · CYP3A4 inhibitors The effect of strong CYP3A4 inhibitors on the PK of mavacamten was not investigated in a cli
Eintrag öffnenCeplene · 4.8 · Ceplene and low dose IL-2 have been investigated in other clinical studies at different doses (1 mg histamine
Eintrag öffnenCholib · 4.5 · Whether fenofibrate had an effect on other active metabolites of simvastatin was not investigated.
Eintrag öffnenCholib · 4.5 · Whether fenofibrate had an effect on other active metabolites of simvastatin was not investigated.
Eintrag öffnen